"/> Novus Biologicals™ Peptide bloquant d’anticorps OC… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps OCIAD2

Réf. : BL-RE-054698Réf. fabricant : 18286888
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
132299
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77085. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

17 amino acids near the amino terminus of OCIAD2. Source: Synthetic (Accession #: NP_001014446) The OCIAD2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-054698
Réf. fabricant18286888
Gene ID (Entrez)132299
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77085. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneMGC45416, OCIA domain containing 2, OCIA domain-containing protein 2, ovarian carcinoma immunoreactive antigen, ovarian carcinoma immunoreactive antigen-like protein
Symbole de gène(s)OCIAD2
Type de produitOCIAD2
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne17 amino acids near the amino terminus of OCIAD2
Une question, une configuration particulière ?
Contactez-nous pour un devis.